Pipeline

Pipeline

Current
Accomplishments

2016

Completed Clinical Studies

July 2017

De Novo submission to the US Food & Drug Administration (FDA), with an anticipated approval by September 2017

Upcoming
Developments

2017

Develop a comprehensive patient registry

2017-2018

  • 3 new games from Ubisoft
  • Begin additional amblyopia clinical studies in pediatrics, adolescents, and adults

2018

Initiate clinical investigation to support an indication in the management of stereopsis, or lack of depth perception

2019

Seeking indication for 3D deficiency

Site map          Privacy Policy          Contact us

Amblyotech is a registered trademark of Amblyotech, Inc. • All other marks used herein are the property of their respective owners. • ©2017 Amblyotech, Inc. All rights reserved.